Concord Healthcare (HKG:2453) agreed to place 48.72 million new H shares at HK$5.54 each to no fewer than six institutional or professional investors to raise net proceeds of about HK$258.8 million, according to a Tuesday filing.
The placing price represents a 16.9% discount to the company's last closing price on July 21 and a 19.9% discount to the five-day average closing price.
The new shares represent about 18.38% of Concord's issued H shares and 6.63% of its total issued share capital before the placement.
Proceeds will be used to fund the construction of a Shanghai cancer hospital, support medical AI operations, repay financial institution loans, and supplement general working capital, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。